Clinical Trial Update: PI-88 in Treating Patients With an Advanced Malignancy (Cancer) or Stage IV Melanoma [Phase 1, Phase 2]

View source ↗

Summary

A completed phase 1/2 trial evaluating PI-88 in patients with melanoma and unspecified adult solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Unspecified Adult Solid Tumor

Drugs mentioned

• PI-88

Snippet

Sponsor: Cellxpert Biotechnology Corp. | Conditions: Melanoma (Skin), Unspecified Adult Solid Tumor, Protocol Specific | Phase 1, Phase 2 | Status: COMPLETED